Cardio Diagnostics Holdings, Inc. (CDIO)
CDIONASDAQ-CMBiotechnology: In Vitro & In Vivo Diagnostic Substances
$1.83
+0.1790 (+10.84%) today
At the close, Nov 9, 4:00 PM ET. After hours $1.83 +1.67%
- Market cap
- $5.33m
- P/E
- –
- EPS, last 4 quarters
- –
- Dividend yield
- –
- Day range
- $1.65 to $1.83
- 52-week range
- $0.9700 to $7.91
- Average volume
- 27.4k
- Previous close
- $1.65
Earnings
Next report
Financials
| Quarter | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | $3,000 | $4,000 | $3,000 | $5,000 |
| Gross profit | $3,000 | $4,000 | $3,000 | $5,000 |
| Operating income | -$1.71m | -$1.46m | -$1.78m | -$1.50m |
| Net income | -$1.72m | -$1.47m | -$1.79m | -$1.50m |
Last four quarters: revenue $15.0k, margin -43126.7%, free cash flow –
News
3 latest- Cardio Diagnostics Expands Global Footprint; Set To Launch PrecisionCHD In India; Stock Surges RTTNews · Jan 7, 2026
- Cardio Diagnostics Regains Nasdaq Compliance After Reverse Stock Split RTTNews · May 29, 2025
- $CDIO stock is up 15% today. Here's what we see in our data.Quiver Quantitative · Feb 7, 2025
The company
Cardio Diagnostics is an artificial intelligence-powered precision cardiovascular medicine company that makes cardiovascular disease prevention, detection, and management more accessible, personalized, and precise. The Company was formed to further develop and commercialize clinical tests by leveraging a proprietary Artificial Intelligence (AI)-driven Integrated Genetic-Epigenetic Engine ('Core Technology') for cardiovascular disease to become one of the leading medical technology companies for improving prevention, detection, and treatment of cardiovascular disease.
- Sector
- Health Care
- Industry
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Exchange
- NASDAQ-CM
- Region
- North America
- Website
- cdio.ai
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.